Top Markets
#1 Bedrock Bedrock +24.46%
#2 iExec RLC iExec RLC +22.99%
#3 API3 API3 +21.64%
#4 CyberDEX CyberDEX +19.33%
#5 Radicle Radicle +19.03%
#6 Talus Network Talus Network +18.92%
#7 The Bitcoin Bull The Bitcoin Bull +16.86%
#8 Orca Orca +13.08%
#9 VeThor VeThor +12.76%
#10 Nockchain Nockchain +11.65%
Coin of the day
Bedrock Bedrock
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
Peringkat dalam Saham #28207
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Harga Saham
$0.4
Terakhir disinkronkan: 2026-10-02
Kapitalisasi Pasar
$27.18M
Perubahan (1 hari)
-14.88%
Perubahan (1 tahun)
8.11%
Negara
US
Perdagangan Cell Source, Inc. (CLCS)

Kategori

Healthcare
Riwayat harga saham Cell Source, Inc. (CLCS)
Harga penutupan tertinggi: $0.43 pada 2026-10-01

Harga penutupan terendah: $0.88 pada 2014-05-01
Riwayat harga saham Cell Source, Inc. dari 2014 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 57.71%
2025 -22.76%
2024 28.36%
2023 -41.25%
2022 -46.94%
2021 9.84%
2020 34.16%
2019 39.21%
2018 131.41%
2017 -37.38%
2016 -65.99%
2015 149.25%
2014 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $503.48 24.96%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $201.85 632.93%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $125.69 -7.66%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $915.50 16.19%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $767.59 9.52%
CH